policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
policy
AVMA policy on veterinary technology
The AVMA recognizes the value of veterinary technicians as an integral component of veterinary medicine and urges full utilization of veterinary…
policy
Dietary Supplement Health and Education Act of 1994
The Dietary Supplement Health and Education Act of 1994, which defines dietary supplements for use in humans, does not apply to products intended for…
policy
Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process
To help ensure adequate availability of veterinary drugs, the AVMA supports increased funding of the FDA Center for Veterinary Medicine for the NADA…
policy
Inappropriate requests for Drug Enforcement Administration (DEA) registration numbers
The AVMA strongly opposes the use of DEA registration numbers for any purpose other than the one for which it was intended: to provide certification…
policy
Limited prohibition on extralabel drug use
Any regulatory prohibition of extralabel drug use in animals should be science-based and as limited in scope as possible, consistent with protecting…
policy
Restriction of veterinary biologics to veterinarians' use
The AVMA supports USDA efforts to restrict all veterinary biologics used in disease control programs, those with high incidence of reactions, and…
policy
Telemedicine
AVMA is committed to ensuring access to the convenience and benefits afforded by telemedicine, while promoting the responsible provision of…
policy
The veterinary profession's role in addressing the opioid epidemic
AVMA strongly recommends that veterinarians, legislators, state veterinary medical boards, and state pharmacy boards work together to create practical…